438
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Temporal Associations between Sleep and Daytime Functioning in Parkinson’s Disease: A Smartphone-Based Ecological Momentary Assessment

ORCID Icon &
 

ABSTRACT

Objectives/Background

Disruptions to mood, cognition, and other daytime functioning are common and debilitating symptoms of Parkinson’s disease (PD), and there is evidence that sleep problems contribute to these symptoms. However, previous studies are limited by reliance on self-reported sleep and cross-sectional designs. With the aim of assessing sleep as a possible treatment target for improving daytime functioning in PD, we used smartphone-based ecological momentary assessment (EMA) and actigraphy to investigate temporal associations between sleep (objective and subjective) and daytime functioning.

Participants/Methods

Twenty participants with mild-moderate PD wore actigraphs and completed sleep diaries for 14–15 days. They reported daytime functioning (anxiety, positive affect, cognitive function, fatigue, and social function) twice daily via smartphone-administered questionnaires. Multilevel modeling examined whether sleep quantity/quality predicted next-day functioning, and whether current mood (anxiety, positive affect) predicted later sleep.

Results

Average completion rates for sleep diaries and daytime questionnaires were 94% and 91%, respectively. Subjective sleep quality predicted next-day anxiety (B = −.75, SE = .25, p= .003), but objective sleep did not predict any daytime functioning variables (p’s>.112). Positive affect predicted later subjective sleep quality (B = 0.03, SE = .01, p = .003) but not objective sleep quantity/quality (p’s>.107).

Conclusions

We demonstrated the feasibility of using EMA in PD. On a daily timescale, subjective sleep quality was bidirectionally associated with mood, whereas objective sleep was not associated with any daytime functioning. This discrepancy suggests that perception of sleep is important for mood in PD, which could provide targets for non-pharmacological interventions.

Acknowledgments

We acknowledge with gratitude the assistance of Mikas Hansen and Asher Le with participant recruitment and data management, and of Sandra Neargarder, Ph.D. with statistical consultation. Marie Saint-Hilaire, MD, FRCPC, and Cathi Thomas, RN, MSN, of the Department of Neurology, Boston Medical Center, provided valuable support of our participant recruitment efforts. We also sincerely thank the individuals who participated in this study for their time and dedication.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

The present work was supported by a Boston University Clara Mayo Research Award to J.Q.W. A.C-G. reports research funding for the past year from the American Parkinson’s Disease Association, the National Institute on Aging, the Veterans Administration, and Boston University.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.